{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:08:39Z","timestamp":1773234519227,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ajo.2006.10.005","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T07:18:59Z","timestamp":1163488739000},"page":"145-149.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Scientific Challenges in Postmarketing Surveillance of Ocular Adverse Drug Reactions"],"prefix":"10.1016","volume":"143","author":[{"given":"Frederick W.","family":"Fraunfelder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick T.","family":"Fraunfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2006.10.005_bib1","series-title":"Ophthalmology Times","first-page":"4","article-title":"Are you skeptical of the latest peer-reviewed results?","author":"McDonnell","year":"2006"},{"key":"10.1016\/j.ajo.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajo.2006.10.005_bib3","series-title":"The Economist","first-page":"72","article-title":"Scientific accuracy\u2026and statistics","year":"2005"},{"key":"10.1016\/j.ajo.2006.10.005_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajo.2006.10.005_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041327-200503000-00003","article-title":"Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases","volume":"25","author":"Pomeranz","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0161-6420(03)00847-9","article-title":"Sildenafil-associated NAION","volume":"110","author":"Gandhi","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0161-6420(01)00976-9","article-title":"Sildenafil-associated nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Pomeranz","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00041327-200103000-00006","article-title":"Anterior ischemic optic neuropathy associated with Viagra","volume":"21","author":"Cunningham","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib9","first-page":"291","article-title":"Sildenafil (Viagra) associated anterior ischemic optic neuropathy","volume":"118","author":"Egan","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajo.2005.02.049","article-title":"An overview of visual side effects associated with erectile dysfunction agents","volume":"140","author":"Fraunfelder","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.wno.0000205622.45263.ad","article-title":"Nonarteritic anterior ischemic optic neuropathy, erectile dysfunction drugs, and amiodarone: Is there a relationship?","volume":"26","author":"Fraunfelder","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.wno.0000189059.90057.98","article-title":"Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?","volume":"25","author":"Hayreh","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/WNL.57.9.1730","article-title":"Transient ischemic attack and stroke associated with sildenafil use","volume":"57","author":"Morgan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ajo.2006.10.005_bib14","series-title":"Physicians Desk Reference","first-page":"2552","year":"2002"},{"key":"10.1016\/j.ajo.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.wno.0000177290.09649.38","article-title":"Amiodarone and optic neuropathy: the heart of the matter","volume":"25","author":"Murphy","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9394(99)00016-1","article-title":"Features of amiodarone-induced optic neuropathy","volume":"127","author":"Macaluso","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0025-6196(12)65224-0","article-title":"Optic neuropathy and amiodarone therapy","volume":"62","author":"Feiner","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajo.2006.10.005_bib18","series-title":"Drug-induced ocular side effects","author":"Fraunfelder","year":"2001"},{"key":"10.1016\/j.ajo.2006.10.005_bib19","first-page":"231","article-title":"Optic nerve ultrastructure following amiodarone therapy","volume":"8","author":"Mansour","year":"1988","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archopht.124.5.696","article-title":"Optic neuropathy in patients using amiodarone","volume":"124","author":"Purvin","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib21","series-title":"Oregonian","first-page":"C1","article-title":"22 million damage award to blind man will stand","author":"Roberts","year":"2000"},{"key":"10.1016\/j.ajo.2006.10.005_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/bjo.80.9.854","article-title":"Widespread use of topical chloramphenicol","volume":"80","author":"Ursell","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bjo.80.2.182","article-title":"Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anemia?","volume":"80","author":"McGhee","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib24","first-page":"44","article-title":"Topical chloramphenicol for eye infections","volume":"8","author":"Lam","year":"2002","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ajo.2006.10.005_bib25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bmj.310.6989.1217","article-title":"Use of chloramphenicol as topical eye medication: time to cry halt?","volume":"310","author":"Doona","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0002-9394(14)73653-0","article-title":"Blood dyscrasias and topical ophthalmic chloramphenicol","volume":"115","author":"Fraunfelder","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.10.005_bib27","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJM198306233082514","article-title":"Ocular chloramphenicol and aplastic anemia","volume":"308","author":"Fraunfelder","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2006.10.005_bib28","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.1982.03320430023016","article-title":"Fatal aplastic anemia","volume":"247","author":"Fraunfelder","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2006.10.005_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/eye.1998.221","article-title":"Lack of evidence for systemic toxicity following topical chloramphenicol use","volume":"12","author":"Walker","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2006.10.005_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0161-6420(90)32406-5","article-title":"Seven hundred medicolegal cases in ophthalmology","volume":"97","author":"Bettman","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0039-6257(95)80031-X","article-title":"Medication errors result in costly claims for ophthalmologists","volume":"40","author":"Brick","year":"1995","journal-title":"Surv Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406011421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406011421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:53:58Z","timestamp":1757595238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939406011421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0002939406011421"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2006.10.005","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific Challenges in Postmarketing Surveillance of Ocular Adverse Drug Reactions","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2006.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}